Kanthi Galappathi
Overview
Explore the profile of Kanthi Galappathi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
883
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wegner C, Hauge A, Gaustad J, Andersen L, Simonsen T, Galappathi K, et al.
Acta Oncol
. 2017 Jun;
56(12):1754-1762.
PMID: 28661213
Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with poor outcome. Resistance to treatment is associated with impaired vascularity, extensive hypoxia, and interstitial hypertension. In this study, the potential...
2.
Andersen L, Wegner C, Simonsen T, Huang R, Gaustad J, Hauge A, et al.
Oncotarget
. 2017 Jun;
8(29):48060-48074.
PMID: 28624797
Pancreatic ductal adenocarcinoma (PDAC) patients develop lymph node metastases early and have a particularly poor prognosis. The poor prognosis has been shown to be associated with the physicochemical microenvironment of...
3.
Rofstad E, Huang R, Galappathi K, Andersen L, Wegner C, Hauge A, et al.
Oncotarget
. 2016 Aug;
7(35):56986-56997.
PMID: 27486768
Studies of cell line-derived human tumor xenografts have suggested that the lymphatics seen in immunohistochemical preparations from non-peripheral regions of tumors are nonfunctional. In this investigation, lymphangiogenesis, hemangiogenesis, and lymph...
4.
Rofstad E, Simonsen T, Huang R, Andersen L, Galappathi K, Ellingsen C, et al.
Cancer Lett
. 2016 Feb;
373(2):147-55.
PMID: 26828134
Patient-derived xenograft (PDX) models of cancer are considered to reflect the biology and treatment response of human tumors to a larger extent than xenograft models initiated from established cell lines....
5.
Ellingsen C, Andersen L, Galappathi K, Rofstad E
BMC Cancer
. 2015 Oct;
15:805.
PMID: 26502718
Background: There is significant evidence that severe tumor hypoxia may cause resistance to chemoradiotherapy and promote metastatic spread in locally advanced carcinoma of the uterine cervix. Some clinical investigations have...
6.
Rofstad E, Galappathi K, Mathiesen B
Neoplasia
. 2014 Aug;
16(7):586-94.
PMID: 25117980
High microvascular density (MVD) in the primary tumor has been shown to be associated with increased incidence of lymph node metastases and poor clinical outcome. Other investigations have revealed that...
7.
Hompland T, Ellingsen C, Galappathi K, Rofstad E
BMC Cancer
. 2014 Feb;
14:92.
PMID: 24528854
Background: Cancer patients with primary tumors showing extensive hypoxia and highly elevated interstitial fluid pressure (IFP) have poor prognosis. The potential of diffusion-weighted magnetic resonance imaging (DW-MRI) in assessing the...
8.
Ellingsen C, Hompland T, Galappathi K, Mathiesen B, Rofstad E
Radiother Oncol
. 2013 Nov;
110(2):335-41.
PMID: 24231244
Background And Purpose: Locoregional treatment failure and poor survival rates are associated with extensive hypoxia in the primary tumor in advanced cervical carcinoma. The potential of gadolinium diethylene-triamine penta-acetic acid...
9.
Hompland T, Ellingsen C, Galappathi K, Rofstad E
Acta Oncol
. 2013 Mar;
53(1):6-15.
PMID: 23445339
Abstract Background. A high fraction of stroma in malignant tissues is associated with tumor progression, metastasis, and poor prognosis. Possible correlations between the stromal and physiologic microenvironments of tumors and...
10.
Ovrebo K, Ellingsen C, Galappathi K, Rofstad E
Int J Radiat Oncol Biol Phys
. 2012 Mar;
83(1):e121-7.
PMID: 22381901
Purpose: Gadolinium diethylene-triamine penta-acetic acid (Gd-DTPA)-based dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has been suggested as a useful noninvasive method for characterizing the physiologic microenvironment of tumors. In the present...